Heart Failure Clinical Trials
150 studies are recruiting for heart failure in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 4
-
Quantifying New Heart Muscle Cells
Regenerative therapies could provide new ways of treating heart failure. Unlike many organs in the human body, such as the skin and the GI tract, the ability to regenerate heart muscle decreases after birth, but the precise timing of this decrease and how this decrease is altered in heart disease a…
- Stage
- Not phased
- Ages
- 0 to 1
- Site
- Weill Cornell Medicine, New York, New York
- Locations
- 4 in total
- Run by
- Weill Medical College of Cornell University
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Banner-University Medical Center Phoenix, Phoenix, Arizona
- Locations
- 68 in total
- Run by
- Abbott Medical Devices
-
Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
The primary objective of the study is to develop, implement, and evaluate a site-specific clinical pathway for at-home treatment of eligible patients presenting to the clinic with worsening heart failure. The secondary objectives are: 1. To evaluate patient factors related to parenteral decongestio…
- Stage
- Phase 4
- Ages
- 18 to 80
- Site
- University of Florida, Gainesville, Florida
- Run by
- University of Florida
-
CALM Study: Cardiomems Assisted Lvad Management
This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the control patients receiving standard of care treatment.
- Stage
- Not phased
- Ages
- 21 to 85
- Site
- Baylor Scott & White The Heart Hospital - Plano, Plano, Texas
- Run by
- Baylor Research Institute
-
Home-based Cardiac Rehabilitation in Heart Failure
This study evaluates a mobile health (mHealth) home-based cardiac rehabilitation program for patients with heart failure. We will stratify randomization between rural and urban populations, with the goal to assess implementation of cardiac rehabilitation across these two geographic areas. . The stu…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- University of Texas Southwestern Medical Center, Dallas, Texas
- Locations
- 2 in total
- Run by
- University of Texas Southwestern Medical Center
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
This prospective, multicenter, cluster-randomized controlled study aims to evaluate the accuracy of an investigational artificial intelligence (AI) Software as a Medical Device (SaMD) designed to compute ejection fraction (EF) severity categories based on the American Society of Echocardiography's …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Orange County Heart Institute, Orange, California
- Locations
- 8 in total
- Run by
- Peerbridge Health, Inc
-
IEEM-Heat and Heart Failure
We will test the hypothesis that increasing skin wetness, and thus evaporative cooling, will attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions in individuals with congestive heart failure. Secondly, we propose that wearing a water-saturated …
- Stage
- Not phased
- Ages
- 45 and older
- Site
- Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 1
This study will employ a randomized order, double-blind, repeated measures dose ranging design. This design was chosen in order to generate multiple within-subject serial loop diuretic dose response exposures. The overall study schema will include 75 heart failure (HF) patients.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Yale University, New Haven, Connecticut
- Run by
- Yale University
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Randomized double-blind placebo-controlled crossover study design
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Yale University, New Haven, Connecticut
- Run by
- Yale University
-
CV Imaging of Metabolic Interventions
Cardiovascular disease is the leading cause of death worldwide. It is becoming clearer that heart failure (HF) is closely associated with body's metabolism. Even before the heart becomes weaker, it responds to the stresses by changing the fuels it burns, which results in a reduction in the heart's …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cardiovascular Innovation Research Center, Cleveland, Ohio
- Run by
- The Cleveland Clinic
-
Development of CIRC Technologies
Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing ra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cardiovascular Innovation Research Center, Cleveland, Ohio
- Run by
- The Cleveland Clinic
-
Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF
EAGLE-HF (Early Assessment and initiation of GuideLine-directed Evidence-based management-HF) is a prospective single site study of a multinational, unblinded, randomized-controlled, longitudinal trial called SYMPHONY. Primary, secondary and exploratory outcomes that are part of SYMPHONY are not de…
- Stage
- Not phased
- Ages
- 40 and older
- Site
- Cleveland Clinic, Cleveland, Ohio
- Run by
- The Cleveland Clinic
-
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
- Stage
- Not phased
- Ages
- Any age
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- University of Missouri-Columbia, Columbia, Missouri
- Run by
- Bettina Mittendorfer
-
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
The goals of this project are to determine the effectiveness of acute (2 hours after a single dose) and chronic (after 6 weeks of once-a-day dosing) KNO3 treatment (10mmol) vs. placebo on quadriceps muscle power and on aerobic exercise performance (V̇O2peak) in patients with HFrEF (left ventricular…
- Stage
- Phase 2
- Ages
- 19 to 79
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them wo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Jia-Rong Wu, Lexington, Kentucky
- Run by
- Jia-Rong Wu
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Peak Heart and Vascular, Avondale, Arizona
- Locations
- 12 in total
- Run by
- VDI Technologies
-
Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction
Heart failure (HF) affects more than 6 million adults in the U.S. alone, with increasing prevalence. Cardiovascular congestion with resultant limitation in physical activity is the hallmark of chronic and decompensated HF. The current HF physiologic model suggests that congestion is the result of v…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Duke, Durham, North Carolina
- Run by
- Duke University
-
The Salt Study for Heart Failure
The purpose of this study is to understand if low sodium (cardiac) diet is indeed necessary for better health outcomes in patients who suffered heart failure. This study will investigate the association between sodium intake and risk for 30-day re-admission in Heart Failure (HF) patients.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Robert Wood Johnson Barnabas Hospital - New Brunswick, New Brunswick, New Jersey
- Run by
- Maya Guglin, MD
-
Cardiovascular Health Improvement Project
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
- Stage
- Not phased
- Ages
- Any age
- Site
- University of Michigan, Ann Arbor, Michigan
- Run by
- University of Michigan
-
A Study of Paramedic HF Management
The purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compared to standard care. The investigators want to find out if their approach is better for patients i…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Promoting Well-being and Health in Heart Failure
The focus of this study is to test the efficacy of a 12-week, phone-delivered Positive Psychology-Motivational Interviewing (PP-MI) intervention, with additional twice weekly PP and health behavior text messages for a total of 24 weeks (with interactive, algorithm-driven, goal-focused text messages…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert, Arizona
- Locations
- 92 in total
- Run by
- Cardiac Dimensions, Inc.
-
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor (www.alivecor.com) has developed several electrocardiogram (ECG) devices that interface with iOS and Android smartphones and tablets via various Kardia apps. The current Kardia family of devices can measure single lead and six limb-lead ECGs, depending on the device. KardiaMobile, KardiaMo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 4 in total
- Run by
- AliveCor
-
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care. The main questions i…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- Lakeland Regional Hospital, Lakeland, Florida
- Run by
- Lakeland Regional Health Systems, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.